Abstract
Molecular biology brings to neuroscience the ability to clone receptors and design drugs to fit them. How quickly will ligand screens translate into products and profits?
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Knight, P. Neurobiotech: Issues, No Answers. Nat Biotechnol 7, 1009–1012 (1989). https://doi.org/10.1038/nbt1089-1009
Issue Date:
DOI: https://doi.org/10.1038/nbt1089-1009
- Springer Nature America, Inc.